Does ATORVASTATIN Cause Urinary retention? 198 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 198 reports of Urinary retention have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.3% of all adverse event reports for ATORVASTATIN.
198
Reports of Urinary retention with ATORVASTATIN
0.3%
of all ATORVASTATIN reports
11
Deaths
122
Hospitalizations
How Dangerous Is Urinary retention From ATORVASTATIN?
Of the 198 reports, 11 (5.6%) resulted in death, 122 (61.6%) required hospitalization, and 27 (13.6%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 198 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which ATORVASTATIN Alternatives Have Lower Urinary retention Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM